Janney Montgomery Scott LLC reduced its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 134,834 shares of the medical research company’s stock after selling 747 shares during the period. Janney Montgomery Scott LLC’s holdings in Agilent Technologies were worth $18,114,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after buying an additional 525,214 shares during the last quarter. FMR LLC grew its position in Agilent Technologies by 62.2% in the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock valued at $191,193,000 after acquiring an additional 493,947 shares during the last quarter. Worldquant Millennium Advisors LLC purchased a new stake in Agilent Technologies in the third quarter worth $49,449,000. Jennison Associates LLC lifted its position in shares of Agilent Technologies by 63.3% during the third quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company’s stock worth $87,075,000 after purchasing an additional 227,431 shares during the last quarter. Finally, Ilex Capital Partners UK LLP purchased a new stake in shares of Agilent Technologies during the third quarter valued at $33,087,000.
Insider Buying and Selling
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Agilent Technologies Stock Performance
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Agilent Technologies’s revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.38 EPS. Research analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.
Agilent Technologies Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were given a $0.248 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date was Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.66%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.40%.
Analysts Set New Price Targets
Several research analysts recently commented on the stock. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Bank of America reduced their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Finally, Barclays lowered their target price on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a report on Wednesday, November 27th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Hold” and an average target price of $143.62.
Check Out Our Latest Analysis on Agilent Technologies
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
See Also
- Five stocks we like better than Agilent Technologies
- Most Volatile Stocks, What Investors Need to Know
- Bloom Energy: Powering the Future With Decentralized Energy
- CD Calculator: Certificate of Deposit Calculator
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Investing in the High PE Growth Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.